191 related articles for article (PubMed ID: 15157997)
21. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
22. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
[TBL] [Abstract][Full Text] [Related]
23. 'Proton magnetic resonance spectroscopy (1H-MRS) in children with spastic diplegia'.
Kulak W; Sobaniec W
Dev Med Child Neurol; 2004 Apr; 46(4):287-8; author reply 288. PubMed ID: 15077707
[No Abstract] [Full Text] [Related]
24. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
25. Gray and white matter brain chemistry in young children with autism.
Friedman SD; Shaw DW; Artru AA; Dawson G; Petropoulos H; Dager SR
Arch Gen Psychiatry; 2006 Jul; 63(7):786-94. PubMed ID: 16818868
[TBL] [Abstract][Full Text] [Related]
26. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
27. [Proton MR spectroscopy of the brain in patients with congenital myotonic dystrophy].
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
No To Hattatsu; 1995 May; 27(3):177-83. PubMed ID: 7662403
[TBL] [Abstract][Full Text] [Related]
28. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
29. [(1)H-magnetic resonance spectroscopy on bilateral thalamus of patients with secondarily generalized tonic-clonic seizures].
Wang M; Li S; Zhou G; Liao W; Li G; Xiao B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 37(11):1147-51. PubMed ID: 23202629
[TBL] [Abstract][Full Text] [Related]
30. Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis.
Wootton-Gorges SL; Buonocore MH; Kuppermann N; Marcin JP; Barnes PD; Neely EK; DiCarlo J; McCarthy T; Glaser NS
AJNR Am J Neuroradiol; 2007 May; 28(5):895-9. PubMed ID: 17494665
[TBL] [Abstract][Full Text] [Related]
31. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
32. A repeat proton magnetic resonance spectroscopy study in social phobia.
Tupler LA; Davidson JR; Smith RD; Lazeyras F; Charles HC; Krishnan KR
Biol Psychiatry; 1997 Sep; 42(6):419-24. PubMed ID: 9285077
[TBL] [Abstract][Full Text] [Related]
33. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
34. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
[TBL] [Abstract][Full Text] [Related]
35. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
36. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
[TBL] [Abstract][Full Text] [Related]
38. Reduced N-acetylaspartate in the brain observed on in vivo proton magnetic resonance spectroscopy in patients with mental retardation.
Hashimoto T; Tayama M; Miyazaki M; Yoneda Y; Yoshimoto T; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 Oct; 13(3):205-8. PubMed ID: 8554657
[TBL] [Abstract][Full Text] [Related]
39. [Regional effects of age and sex in magnetic resonance spectroscopy].
García Santos JM; Fuentes LJ; Vidal JB; Antequera M; Torres Del Río S; Antúnez C; Ortega G
Radiologia; 2010; 52(4):342-50. PubMed ID: 20557913
[TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
